Clinical trials


  • Despite the unique characteristics of Ambroxol regarding the stimulation of TFEB, you have to go about 10 years before you see physical symptoms of Alzheimer’s. If you go much later, the system becomes much more difficult to clear. The advances in biomarkers enable us to pick a time, 10 years out.